Navigation Links
Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence
Date:6/13/2008

CHAPEL HILL, N.C., June 13 /PRNewswire/ -- Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value. Leading companies are integrating commercial insights earlier and earlier into the new product process in an effort to identify and target promising compounds, reduce development cycle time, focus resources for greatest impact and increase their potential for launching a blockbuster drug.

Early-Stage Commercialization activities range from therapeutic opportunity and competitive landscape assessments to thought-leader focus groups, initial pricing studies, and pre-efficacy forecasts during pre-clinical and Phases I and II development. Global pharmaceutical companies must find ways to improve early-stage decision making and enhance product design using commercial insights to gain an overall competitive advantage in the marketplace. With these issues top of mind, Best Practices, LLC conducted primary benchmark research newly published in the report, "Best Practices in New Product Commercialization."

In a benchmarking study that included such influential companies as Abbott, Allergan, Amgen, AstraZeneca, Bayer, Eli Lilly, Genentech, GSK, Merck and Novartis, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.

For a complimentary summary of the full report "Best Practices in New Product Commercialization," click on the following link http://www3.best-in-class.com/rr958.htm .

Key topic areas in the research include:

-- Early Commercialization Structure

-- Functional Involvement in Commercialization Activities

-- Cross-Functional & Regional Collaboration

-- Essential Employee Skills & Experience

-- Investment Decision Leaders

-- Value of Early Commercialization

-- Product Commercialization Success Factors

Among the key metrics gathered in this report are:

-- Commercialization Function Oversight

-- Organizational Structure

-- Commercialization Relationship with Global Marketing

-- Commercialization Leadership Levels

-- Commercialization Functional Structure

-- Commercialization Function Resources (FTEs)

-- Commercialization Functional Responsibilities

-- Commercialization Launch Responsibilities

-- Commercialization Key Stakeholders

-- Commercialization Communication

-- Product Portfolio Decision Committee Composition

-- Investment Decision Drivers

For more information on this report, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/rr958.htm .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more than 15 years, our highly credentialed research staff has conducted primary research exclusively for our Fortune 500 client base.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
2. Tourtellotte Solutions Fusion DMC(TM) Unifies the World of Bio-Pharma Documents
3. Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
4. Best Practice Database Supports Bio-Pharma M&A Integration with New Publication
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. UPMC Health Plan Launches New Personal Health Record
7. HealthInsuranceFinders.com Launches Video Contest for Young Directors
8. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
9. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
10. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
11. Mannatech Launches Phase One of New Sales and Training Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology: